Literature DB >> 8789064

Recognition of nonstructural protein peptides by cytotoxic T lymphocytes raised against Japanese encephalitis virus.

K Murali-Krishna1, B Ramireddy, V Ravi, R Manjunath.   

Abstract

We have previously reported that Lyt2+ cytotoxic T lymphocytes (CTL) can be raised against Japanese encephalitis virus (JEV) in BALB/c mice. In order to confirm the presence of H-2Kd-restricted CTL and to examine their cross-recognition of West Nile virus (WNV), we tested the capacity of anti-JEV CTL to lyse uninfected syngeneic target cells that were pulsed with synthetic peptides. The sequence of the synthetic peptides was predicted based upon the H-2Kd binding consensus motif. We show here that preincubation of uninfected syngeneic targets (P388D1) with JEV NS1- and NS3-derived peptides [NS1 (891-899) and NS3 (1804-1812)], but not with JEV NS5-derived peptide [NS5 (3370-3378)], partially sensitized them for lysis by polyclonal anti-JEV CTL. These results indicate the CTL recognition of NS1- and NS3-derived peptides of JEV.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8789064     DOI: 10.1111/j.1348-0421.1995.tb03294.x

Source DB:  PubMed          Journal:  Microbiol Immunol        ISSN: 0385-5600            Impact factor:   1.955


  3 in total

1.  Protective mechanisms induced by a Japanese encephalitis virus DNA vaccine: requirement for antibody but not CD8(+) cytotoxic T-cell responses.

Authors:  C H Pan; H W Chen; H W Huang; M H Tao
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

2.  Virus-specific cytolytic antibodies to nonstructural protein 1 of Japanese encephalitis virus effect reduction of virus output from infected cells.

Authors:  Venkatramana D Krishna; Manjuladevi Rangappa; Vijaya Satchidanandam
Journal:  J Virol       Date:  2009-03-04       Impact factor: 5.103

3.  Protective immunity to Japanese encephalitis virus associated with anti-NS1 antibodies in a mouse model.

Authors:  Yize Li; Dorian Counor; Peng Lu; Veasna Duong; Yongxin Yu; Vincent Deubel
Journal:  Virol J       Date:  2012-07-24       Impact factor: 4.099

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.